- Home
- ETON vs JAKK Comparison
ETON vs JAKK Comparison
Compare ETON & JAKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- JAKK
- Stock Information
- Founded
- ETON 2017
- JAKK 1995
- Country
- ETON United States
- JAKK United States
- Employees
- ETON N/A
- JAKK N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- JAKK Recreational Games/Products/Toys
- Sector
- ETON Health Care
- JAKK Consumer Discretionary
- Exchange
- ETON Nasdaq
- JAKK Nasdaq
- Market Cap
- ETON 428.5M
- JAKK 216.9M
- IPO Year
- ETON 2018
- JAKK 1996
- Fundamental
- Price
- ETON $17.14
- JAKK $19.46
- Analyst Decision
- ETON Strong Buy
- JAKK Strong Buy
- Analyst Count
- ETON 3
- JAKK 4
- Target Price
- ETON $27.67
- JAKK $41.75
- AVG Volume (30 Days)
- ETON 221.4K
- JAKK 164.2K
- Earning Date
- ETON 05-13-2025
- JAKK 04-29-2025
- Dividend Yield
- ETON N/A
- JAKK 2.71%
- EPS Growth
- ETON N/A
- JAKK 47.04
- EPS
- ETON N/A
- JAKK 4.03
- Revenue
- ETON $39,011,000.00
- JAKK $714,219,000.00
- Revenue This Year
- ETON $92.33
- JAKK $2.34
- Revenue Next Year
- ETON $52.62
- JAKK $4.14
- P/E Ratio
- ETON N/A
- JAKK $4.58
- Revenue Growth
- ETON 23.29
- JAKK 2.89
- 52 Week Low
- ETON $3.18
- JAKK $17.06
- 52 Week High
- ETON $18.41
- JAKK $35.79
- Technical
- Relative Strength Index (RSI)
- ETON 70.21
- JAKK 46.50
- Support Level
- ETON $16.43
- JAKK $17.75
- Resistance Level
- ETON $17.49
- JAKK $19.81
- Average True Range (ATR)
- ETON 0.85
- JAKK 1.09
- MACD
- ETON 0.18
- JAKK 0.30
- Stochastic Oscillator
- ETON 98.09
- JAKK 38.46
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.